Xia et al. have uncovered that Mesothelin (MSLN) expression was significantly elevated in both serum and tumor tissue from NSCLC-BM patients and was correlated with a poor clinical prognosis [36]. The gene discussed is MSLN; the disease is non-small cell lung carcinoma.